Resistance to Chemotherapy in ovarian cancer is a result of high ELAVL2 expression of protein in tumour cells that encourages tumour growth, invasion, and migration, disturbs the cell cycle, and blocks tumor cell apoptosis brought on by chemotherapeutic medicines through a variety of routes. The gene discussed is ELAVL2; the disease is ovarian carcinoma.